Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer-Letter

被引：21
|
作者：
Radvanyi, Laszlo [1 ]
Pilon-Thomas, Shari [2 ]
Peng, Weiyi [1 ]
Sarnaik, Amod [2 ]
Mule, James J. [2 ]
Weber, Jeffrey [2 ]
Hwu, Patrick [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA
[2] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Cutaneous Oncol Dept, Tampa, FL 33612 USA
来源：
CLINICAL CANCER RESEARCH | 2013年 / 19卷 / 19期
关键词：
MELANOMA;
D O I：
10.1158/1078-0432.CCR-13-1054
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5541 / 5541
页数：1
相关论文
共 50 条
  • [11] PD-1, PD-L1 (B7-H1) and Tumor-Site Immune Modulation Therapy: The Historical Perspective
    Jun Wang
    Ruirong Yuan
    Wenru Song
    Jingwei Sun
    Delong Liu
    Zihai Li
    Journal of Hematology & Oncology, 10
  • [12] The STATus of PD-L1 (B7-H1) on tolerogenic APCs
    Sumpter, Tina L.
    Thomson, Angus W.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2011, 41 (02) : 286 - 290
  • [13] PD-1, PD-L1 (B7-H1) and Tumor-Site Immune Modulation Therapy: The Historical Perspective
    Wang, Jun
    Yuan, Ruirong
    Song, Wenru
    Sun, Jingwei
    Liu, Delong
    Li, Zihai
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
  • [14] Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
    Annika De Sousa Linhares
    Claire Battin
    Sabrina Jutz
    Judith Leitner
    Christine Hafner
    Joshua Tobias
    Ursula Wiedermann
    Michael Kundi
    Gerhard J. Zlabinger
    Katharina Grabmeier-Pfistershammer
    Peter Steinberger
    Scientific Reports, 9
  • [15] Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
    Linhares, Annika De Sousa
    Battin, Claire
    Jutz, Sabrina
    Leitner, Judith
    Hafner, Christine
    Tobias, Joshua
    Wiedermann, Ursula
    Kundi, Michael
    Zlabinger, Gerhard J.
    Grabmeier-Pfistershammer, Katharina
    Steinberger, Peter
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [16] Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy
    Wu, Xiaosheng
    Li, Yanli
    Liu, Xin
    Chen, Chunhua
    Harrington, Susan M.
    Cao, Siyu
    Xie, Tiancheng
    Orzechowski, Amanda
    Tu Pham
    Mansfield, Aaron S.
    Yan, Yiyi
    Kwon, Eugene D.
    Wang, Liewei
    Ling, Kun
    Dong, Haidong
    HELIYON, 2018, 4 (12):
  • [17] Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity
    Hirano, F
    Kaneko, K
    Tamura, H
    Dong, HD
    Wang, SD
    Ichikawa, M
    Rietz, C
    Flies, DB
    Lau, JS
    Zhu, GF
    Tamada, K
    Chen, LP
    CANCER RESEARCH, 2005, 65 (03) : 1089 - 1096
  • [18] Concordance of PD-1 and PD-L1 (B7-H1) in paired primary and metastatic clear cell renal cell carcinoma
    Eckel-Passow, Jeanette E.
    Ho, Thai H.
    Serie, Daniel J.
    Cheville, John C.
    Thompson, R. Houston
    Costello, Brian A.
    Dong, Haidong
    Kwon, Eugene D.
    Leibovich, Bradley C.
    Parker, Alexander S.
    CANCER MEDICINE, 2020, 9 (03): : 1152 - 1160
  • [19] The PD-1/PD-L1 (B7-H1) Pathway in Chronic Infection-Induced Cytotoxic T Lymphocyte Exhaustion
    Hofmeyer, Kimberly A.
    Jeon, Hyungjun
    Zang, Xingxing
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2011,
  • [20] PD-L1 (B7-H1) regulation in zones of axonal degeneration
    Lipp, Michael
    Brandt, Christine
    Dehghani, Faramarz
    Kwidzinski, Erik
    Bechmann, Ingo
    NEUROSCIENCE LETTERS, 2007, 425 (03) : 156 - 161
12345